Travoprost

Brand Names: iDose TR

Drug Class: Prostaglandin analog

Overview

iDose TR (travoprost intracameral implant) is a sustained-release prostaglandin analog implant indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It provides continuous drug delivery directly into the anterior chamber, offering an alternative to daily topical eye drops.

Mechanism of Action

Travoprost is a synthetic prostaglandin F2α analog that reduces intraocular pressure by increasing uveoscleral outflow of aqueous humor through prostaglandin receptor activation in the ciliary muscle.

Indications

  • Reduction of intraocular pressure in patients with open-angle glaucoma
  • Reduction of intraocular pressure in patients with ocular hypertension

Common Doses

  • Single intracameral implant (providing sustained travoprost release)

Dosage

Single intracameral implant administered by a healthcare professional during a minor surgical procedure. The implant provides sustained travoprost release for approximately 6 months.

Contraindications

  • Active or suspected ocular or periocular infections
  • Corneal endothelial dystrophy
  • Prior corneal transplantation
  • Hypersensitivity to travoprost or any component of the formulation

Side Effects

  • Device dislocation
  • Macular edema
  • Intraocular inflammation
  • Increased iris pigmentation
  • Endophthalmitis
  • Ocular hyperemia
  • Eye pain
  • Foreign body sensation
  • Visual disturbances

Interactions

  • No specific drug-drug interactions identified for the intracameral implant formulation. As a prostaglandin analog, theoretical interactions with other ocular hypotensive agents may occur when used concomitantly.

Counseling Points

  • This is an implant placed inside the eye during a minor surgical procedure
  • Regular follow-up visits are essential to monitor intraocular pressure and implant position
  • Report any signs of infection, increased eye redness, pain, or vision changes immediately
  • The implant provides continuous medication release for approximately 6 months
  • Continue all other prescribed medications unless instructed otherwise by your ophthalmologist